BCI-215
CAS: 1245792-67-9
Ref. 3D-VZB79267
| 5mg | Discontinued | ||
| 10mg | Discontinued | ||
| 25mg | Discontinued | ||
| 50mg | Discontinued | ||
| 100mg | Discontinued |
Product Information
Name:
BCI-215
Synonyms:
- 1H-Inden-1-one, 5-bromo-3-(cyclohexylamino)-2,3-dihydro-2-(phenylmethylene)-, (2E)-
- (2E)-5-Bromo-3-(cyclohexylamino)-2,3-dihydro-2-(phenylmethylene)-1H-inden-1-one
Description:
BCI-215 is a small molecule inhibitor of the extracellular phosphatase, which is an enzyme that dephosphorylates proteins. It has been shown to inhibit the growth of cancer cells. BCI-215 has also been shown to inhibit the activation of mammalian cells, and it can be used in tumorigenicity studies. BCI-215 activates MAP kinase activity in mammalian cells and inhibits growth factor receptor tyrosine kinases. BCI-215 has been targeted for profiling by high throughput screening methods using phosphatases as bait molecules. This drug has demonstrated a phenotype of activating cellular signaling pathways through protein phosphorylation and inhibition of extracellular phosphatases.
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:
Chemical properties
Molecular weight:
396.32 g/mol
Formula:
C22H22BrNO
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
